{
  "ptid_time": "130_S_4971_2013-05-03",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4971/2013-05-03/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,246 mm³, 17.4% below the reference mean. With a Z-score of -1.69 (4.5th percentile), this represents moderate atrophy; whole brain volume measures 1,239,450 mm³, 14.8% above the reference mean. With a Z-score of 1.92 (97.3th percentile), this represents moderate enlargement; entorhinal cortex volume measures 2,228 mm³, 45.7% below the reference mean. With a Z-score of -3.10 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 19,148 mm³, 1.6% above the reference mean. With a Z-score of 0.14 (55.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,527 mm³, 3.8% below the reference mean. With a Z-score of -0.34 (36.6th percentile), this represents normal volume . ",
  "text_data": "Age is 76.9 years. Gender is Male. Education: 18 years. MMSE: 25.0. MoCA: 18.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows **profound atrophy in the entorhinal cortex** (Z-score -3.10, 0.1st percentile) and **moderate hippocampal atrophy** (Z-score -1.69, 4.5th percentile), both strongly associated with Alzheimer’s pathology. Cognitive testing (MoCA 18/30, MMSE 25/30) indicates significant impairment, particularly in executive function and memory (typical of AD). The presence of one APOE4 allele further increases AD risk.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High** (due to severe entorhinal atrophy, hippocampal atrophy, and low MoCA in the dementia range).  \n\n*(Note: Whole brain volume enlargement is atypical but may reflect compensatory mechanisms or individual variation; fusiform/middle temporal volumes are normal, ruling out broader neurodegeneration like FTD.)*",
  "timestamp": "2025-07-26T14:54:22.809996"
}